determin
seropreval
virus
bat
papua
new
guinea
sampl
bat
locat
found
seropreval
henipaviru
hendra
nipah
viru
rubulaviru
tioman
menangl
viru
notabl
bat
survey
contain
antibodi
type
virus
indic
concurr
consecut
infect
genu
henipaviru
famili
paramyxovirida
contain
highli
lethal
virus
hendra
viru
hev
nipah
viru
niv
use
pteropid
bat
main
natur
reservoir
discoveri
hev
australian
fl
ying
fox
mark
begin
new
wave
research
activ
led
associ
bat
notabl
viral
pathogen
emerg
recent
histori
includ
niv
sever
acut
respiratori
syndromelik
coronavirus
ebola
viru
marburg
viru
addit
henipavirus
novel
paramyxovirus
genu
rubulaviru
discov
australia
malaysia
menangl
viru
menpv
isol
australia
diseas
outbreak
pig
epidemiolog
evid
suggest
involv
human
patient
result
pigtohuman
transmiss
tioman
viru
tiopv
isol
bat
urin
collect
tioman
island
malaysia
although
antitiopv
antibodi
detect
resid
island
potenti
caus
diseas
human
unknown
sever
orthoreovirus
also
isol
bat
australia
malaysia
pulau
viru
isol
bat
urin
collect
tioman
island
close
relat
nelson
bay
viru
nbv
isol
pteropid
bat
australia
recent
melaka
viru
kampar
viru
close
relat
virus
nbv
speci
group
isol
human
patient
respiratori
symptom
epidemiolog
investig
strongli
suggest
caus
agent
broom
viru
brov
new
orthoreoviru
speci
isol
sick
littl
red
fl
ying
fox
pteropu
scapulatu
australia
diseasecaus
potenti
unknown
studi
conduct
june
survey
bat
papua
new
guinea
determin
presenc
variou
known
bat
virus
assess
potenti
virus
transmit
bat
popul
australia
total
bat
caught
locat
papua
new
guinea
figur
onlin
appendix
tabl
wwwcdc
anesthet
use
combin
ketamin
medetomidin
dose
similar
state
previou
studi
blood
sampl
held
room
temperatur
hour
serum
separ
use
centrifug
requir
serum
sampl
held
ship
australian
anim
health
laboratori
virusspecifi
c
antibodi
detect
use
varieti
assay
previous
develop
group
australian
anim
health
laboratori
henipavirus
luminexbas
bind
inhibit
assay
use
initi
screen
posit
sampl
confi
rmed
viru
neutral
test
vnt
posit
result
assay
shown
onlin
appendix
tabl
tiopv
menpv
initi
screen
conduct
use
elisa
purifi
ed
tiopv
virion
antigen
elisaposit
sampl
confi
rmed
vnt
viru
virus
nbv
speci
group
mixtur
purifi
ed
recombin
sigma
c
protein
nbv
pulau
viru
melaka
viru
kampar
viru
use
elisa
antigen
initi
screen
posit
sampl
confi
rmed
western
blot
recombin
protein
brov
initi
screen
conduct
elisa
use
purifi
ed
virion
antigen
posit
sampl
confi
rmed
immunofl
uoresc
antibodi
test
cell
infect
brov
summari
result
present
onlin
appendix
tabl
seropreval
hev
niv
tiopv
menpv
nbvlike
virus
brov
seropreval
type
paramyxovirus
hevniv
tiopvmenpv
high
strike
fi
nding
presenc
antibodi
group
virus
sampl
consid
vnt
specifi
c
less
sensit
assay
actual
posit
rate
could
compar
result
studi
conduct
madgascar
serum
sampl
contain
vntposit
antibodi
henipaviru
tiopv
fi
nding
suggest
extrem
differ
paramyxoviru
infect
dynam
bat
papua
new
guinea
whether
data
suggest
concurr
consecut
infect
clear
anticip
use
pteropid
immunoglobulin
mspecifi
c
reagent
current
develop
group
clarifi
question
futur
posit
rate
group
paramyxovirus
much
higher
p
conspicillatu
bat
spectacl
fl
ying
fox
madang
dobsonia
magna
bat
bareback
fruit
bat
bensbach
believ
differ
bat
speci
geograph
locat
henipavirus
seropreval
slightli
higher
niv
hev
also
consist
luminex
inhibit
assay
show
trend
slightli
higher
inhibit
niv
hev
data
shown
higher
seropreval
may
suggest
henipavirus
circul
papua
new
guinea
nivlik
hevlik
howev
absenc
genet
sequenc
data
serolog
fi
nding
inconclus
addit
rubulavirus
seropreval
higher
menpv
tiopv
fi
nding
noteworthi
previou
data
indic
oneway
crossneutr
menpv
antibodi
fail
neutral
tiopv
g
crameri
j
barr
unpub
data
result
studi
suggest
either
main
strain
bat
rubulaviru
es
circul
bat
papua
new
guinea
close
relat
menpv
differ
strain
circul
menpvlik
domin
although
overal
seropreval
orthoreovirus
much
lower
result
nevertheless
produc
use
inform
first
preval
nbv
group
virus
magna
bat
bensbach
much
differ
p
conspicillatu
bat
madang
indic
nbv
group
orthoreovirus
present
bat
differ
speci
papua
new
guinea
second
none
serum
sampl
posit
nbv
brov
support
previou
conclus
brov
new
speci
genu
orthoreoviru
signifi
cant
crossreact
occur
brov
orthoreovirus
speci
group
studi
serolog
survey
conduct
group
virus
famili
paramyxovirida
genu
orthoreoviru
famili
reovirida
surpris
fi
nding
high
preval
antibodi
henipavirus
tiopvmenpv
individu
pteropid
bat
highlight
need
structur
studi
investig
infect
dynam
zoonot
virus
differ
bat
popul
across
world
clear
stage
factor
respons
vast
differ
preval
antibodi
paramyxovirus
orthoreovirus
context
potenti
incurs
exot
bat
virus
australia
noteworthi
bat
rubulaviru
es
circul
papua
new
guinea
menpvlik
australia
wherea
papua
new
guinea
henipaviru
es
seem
nivlik
asia
fi
nding
consist
indonesia
call
molecular
epidemiolog
investig
better
assess
risk
niv
entri
australia
emerg
infecti
diseas
wwwcdcgoveid
vol
decemb
